Director/PDMR Shareholding

By

Regulatory News | 07 Dec, 2018

Updated : 16:01

RNS Number : 8716J
Primary Health Properties PLC
07 December 2018
 

 

Primary Health Properties PLC

 

Director/PDMR shareholding

 

The Company has been advised that the following information relating to a transaction by a PCA has been filed today with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

 

 

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Anita Hyman

 

2

Reason for the notification

(a)

Position/status

Notification concerns a PCA, being the wife of Harry Hyman, a PDMR as Managing Director of Primary Health Properties PLC

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

 

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Acquisition in monthly share plan

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.106

 

88

(d)

Aggregated information

Aggregated volume price

 

Single transaction

£97.32

 

(e)

Date of transaction

4 December 2018

 

(f)

Place of transaction

London Stock Exchange (xlon)

 

 

For further information:

 

 

Primary Health Properties PLC

Paul Wright, Nexus Management Services Limited, Company Secretary

+44(0) 20 7451 7050

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBUBDDSXGBGIR

Last news